Early research (Phase 1)Study completedNCT00802555
What this trial is testing
Safety Study of ARQ 197 in Cirrhotic Patients With Hepatocellular Carcinoma (HCC)
Who this might be right for
CirrhosisHepatocellular Carcinoma
ArQule, Inc., a subsidiary of Merck Sharp & Dohme LLC, a subsidiary of Merck & Co., Inc. (Rahway, NJ USA) 21